The effect of SGLT2 inhibitor on diabetic kidney disease-Examination by MRI
Not Applicable
- Conditions
- Diabetic Kidney Disease
- Registration Number
- JPRN-UMIN000036523
- Lead Sponsor
- ational Hospital Organization, Kagosima Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
# Less than eGFR 45 ml/min/1.73m2 # More than 100 U/L of AST or ALT (excluded patients with fatty liver) # Patients who chenged or increased oral hypoglycemic agents within the past 3 months # Pregnant or breastfeeding women # Patients who have diagnosed with malignancy within the past year # Patients who have had a cardiovascular event or stroke within the past year
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes after 24 weeks in ischemic state of kidney on functional MRI images [T2*value, apparent diffusion coefficient (ADC) value]
- Secondary Outcome Measures
Name Time Method